ARMP Receives $2.5M Funding
Armata Pharmaceuticals receives $2.5 million in non-dilutive award funding from the U.S. Department of Defense to support AP-SA02
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.